Scaling for size: some implications for paediatric anaesthesia dosing.
about
Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic studyLimited predictability of amikacin clearance in extreme premature neonates at birthPrenatal and postnatal expression of glutathione transferase ζ 1 in human liver and the roles of haplotype and subject age in determining activity with dichloroacetateThe pharmacokinetics of methadone and its metabolites in neonates, infants, and childrenPopulation pharmacokinetics of remifentanil in infants and children undergoing cardiac surgery.What is the right dose for children?A population pharmacokinetic modeling approach shows that serum penicillin G concentrations are below inhibitory concentrations by two weeks after benzathine penicillin G injection in the majority of young adults.Dose estimation for children.Comparing the efficacy of NSAIDs and paracetamol in children.Methylxanthines for the treatment of apnea associated with bronchiolitis and anesthesia.Estimation of the plasma effect site equilibration rate constant of sufentanil in children using the time to peak effect of heart rate and blood pressure.Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearancePopulation pharmacokinetics of etomidate in neonates and infants with congenital heart disease.Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations.Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass.Developmental pharmacology: neonates are not just small adults...Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial.Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.Pharmacokinetics in special populations.Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance.Buprenorphine TTS for children--a review of the drug's clinical pharmacology.Knowledge-driven approaches for the guidance of first-in-children dosing.Pharmacotherapy for acute pain in children: current practice and recent advances.Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.Medication errors--new approaches to prevention.My child is unique; the pharmacokinetics are universal.The relationship between age and morphine infusion rate in children.Effect of dexmedetomidine combined with sufentanil on preventing emergence agitation in children receiving sevoflurane anesthesia for cleft palate repair surgery.Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics.Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery.Explaining the acetaminophen-ibuprofen analgesic interaction using a response surface model.Use of nonsteroidal anti-inflammatory drugs in infants. A survey of members of the Association of Paediatric Anaesthetists of Great Britain and Ireland.Clonidine disposition in children; a population analysis.Pharmacokinetics of levobupivacaine following infant spinal anesthesia.Pharmacokinetics of dexmedetomidine combined with therapeutic hypothermia in a piglet asphyxia model.Pharmaco-economics: Minute-based cost of sevoflurane in pediatric short procedures and its relation to demographic variables.Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.Target concentration of propofol required to insert the laryngeal mask airway in children.Diclofenac and metabolite pharmacokinetics in children.Is it farewell to codeine?
P2860
Q24679028-FD6EF7D3-F092-4A43-BFF4-125CED54D4B8Q28194278-F339A817-F593-487E-AA7E-C7EDA063063FQ28251446-182CDFAF-4971-4232-AFC1-B3D0911BA3A5Q30393865-25A31B4B-4E3B-4482-8ABD-5662580B218DQ33487458-830887C1-7AFC-41DD-B8E0-88AAAD5BF331Q34180493-DAC9163D-776D-4A34-A21F-1DB1210EC9CDQ34596526-FB38E9B8-B394-486C-BAB2-ADFA9C2F9C3FQ35598801-D575FE1F-2FA2-45CF-9237-01B3B667586CQ35680419-4CFA6897-C429-4496-9635-E9E2D0E70585Q35807488-9D76E96F-6A6A-457C-BC2D-5587ABA1F550Q35922797-EE6CA0F4-FEEE-4D94-B75A-F4249942D800Q36024899-606B66EF-3BFD-4B97-8E53-4610618B4A68Q36239801-32E5B4C4-28A8-4B91-88A0-F06C706E8C1DQ36544972-BF6F3133-5330-4B06-9C5D-53D5453F0AD9Q36941579-E393797C-5E60-4F9C-AFFD-F10DE3F4CB56Q37127683-967A6A01-B093-4EFF-B9F4-DA49ED82D37CQ37322083-D5E0D52A-1B86-450D-97B8-199D33908CC5Q37383670-3E707CB8-9758-4BE6-80BB-3B06DB5DBCFCQ37550561-224782F2-092A-4F15-954C-4D775E674882Q37781110-4FBB9A59-2E29-4367-BB4E-7E615BE495CFQ37811033-02CD89F0-A411-49B0-BA04-47988169E2AFQ37815555-4D4BFEA7-352E-4086-B4B5-EE264C669AE7Q37831316-8C67578B-9701-4521-9685-E3314B4965E6Q37835819-40FFB422-B44D-41D2-8C29-193E7C9B6AB8Q37868727-A7A299D5-A863-443E-A1B2-7332640183ADQ37973872-9D18B34E-E556-4AD2-B39E-709968340474Q38025180-6EC1AFBC-9A7E-4B58-9B5F-4F922966A92FQ38623579-0CB44271-2079-4034-BE09-32C0B0CDB7F1Q38682009-FEDD0F0B-A160-4A46-9BA0-9F859F17CA25Q38937171-DC960DDF-FEDA-4509-B8CB-DD65EC6CA8D8Q39733241-8A65D14E-6187-49EB-BA13-B2BF87CB1740Q42619048-3E5967EC-4D50-45FB-9F1D-3A4D88559107Q42630510-D2B75675-DD84-4AD4-9BC7-F69EFD9D0B26Q42688319-E9564647-E4EC-453A-B429-761F77592D02Q42910260-C8340D21-7472-4615-8C82-D25C611EF63DQ42961077-237C197F-4A5A-4094-92F4-F0703FDA50CAQ44201200-466817F5-3A93-425E-98D3-C14FED9E8951Q44365049-3C425507-8EC7-4171-8746-7F486588AA9DQ44903087-43CA57A2-C594-49E7-9CBC-440F945768DCQ45033609-BACD310D-E0AC-421C-971E-7D7F985EA9C7
P2860
Scaling for size: some implications for paediatric anaesthesia dosing.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Scaling for size: some implications for paediatric anaesthesia dosing.
@ast
Scaling for size: some implications for paediatric anaesthesia dosing.
@en
Scaling for size: some implications for paediatric anaesthesia dosing.
@nl
type
label
Scaling for size: some implications for paediatric anaesthesia dosing.
@ast
Scaling for size: some implications for paediatric anaesthesia dosing.
@en
Scaling for size: some implications for paediatric anaesthesia dosing.
@nl
prefLabel
Scaling for size: some implications for paediatric anaesthesia dosing.
@ast
Scaling for size: some implications for paediatric anaesthesia dosing.
@en
Scaling for size: some implications for paediatric anaesthesia dosing.
@nl
P2860
P1476
Scaling for size: some implications for paediatric anaesthesia dosing.
@en
P2093
Brian J Anderson
George H Meakin
P2860
P304
P356
10.1046/J.1460-9592.2002.00616.X
P577
2002-03-01T00:00:00Z